Dr. Martens plc (LON:DOCS) Insider Kenny Wilson Buys 199 Shares

Dr. Martens plc (LON:DOCSGet Free Report) insider Kenny Wilson acquired 199 shares of the company’s stock in a transaction dated Wednesday, December 11th. The stock was purchased at an average cost of GBX 76 ($0.96) per share, for a total transaction of £151.24 ($190.89).

Kenny Wilson also recently made the following trade(s):

  • On Thursday, September 26th, Kenny Wilson bought 30,000 shares of Dr. Martens stock. The shares were bought at an average cost of GBX 55 ($0.69) per share, for a total transaction of £16,500 ($20,825.44).

Dr. Martens Stock Down 0.6 %

Shares of Dr. Martens stock opened at GBX 76.55 ($0.97) on Friday. The stock’s fifty day moving average is GBX 59.81 and its 200-day moving average is GBX 67.49. The firm has a market capitalization of £736.20 million, a PE ratio of 1,093.57, a price-to-earnings-growth ratio of 6.40 and a beta of 0.11. The company has a quick ratio of 1.13, a current ratio of 2.85 and a debt-to-equity ratio of 129.55. Dr. Martens plc has a 12-month low of GBX 49.32 ($0.62) and a 12-month high of GBX 100 ($1.26).

Dr. Martens Cuts Dividend

The business also recently announced a dividend, which will be paid on Tuesday, April 8th. Stockholders of record on Thursday, March 6th will be given a dividend of GBX 0.85 ($0.01) per share. This represents a dividend yield of 1.47%. The ex-dividend date is Thursday, March 6th. Dr. Martens’s dividend payout ratio (DPR) is presently 4,285.71%.

About Dr. Martens

(Get Free Report)

Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It offers originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.

See Also

Insider Buying and Selling by Quarter for Dr. Martens (LON:DOCS)

Receive News & Ratings for Dr. Martens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dr. Martens and related companies with MarketBeat.com's FREE daily email newsletter.